Rajeswaran Mani

1.1k citations

25 papers · 293 indexed · h-index 9

Co-authors: Natarajan Muthusamy John C. Byrd Robert A. Baiocchi Lapo Alinari Xiaokui Mo Xiaoli Zhang Ching-Shih Chen William H. Towns
Topics: Chronic Lymphocytic Leukemia Research (11 papers)Sphingolipid Metabolism and Signaling (4 papers)CAR-T cell therapy research (3 papers)
Cited by: Hematology Genetics Immunology
Journals: Blood Cancer Research Clinical Cancer Research
Partner nations: United States Poland Austria

In The Last Decade

Rajeswaran Mani

24 papers receiving 290 citations

Peers

Countries citing papers authored by Rajeswaran Mani

Since Specialization

Citations

This map shows the geographic impact of Rajeswaran Mani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajeswaran Mani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajeswaran Mani more than expected).

Fields of papers citing papers by Rajeswaran Mani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajeswaran Mani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajeswaran Mani. The network helps show where Rajeswaran Mani may publish in the future.

Co-authorship network of co-authors of Rajeswaran Mani

This figure shows the co-authorship network connecting the top 25 collaborators of Rajeswaran Mani. A scholar is included among the top collaborators of Rajeswaran Mani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajeswaran Mani. Rajeswaran Mani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TP53 upregulation via aurora kinase inhibition overcomes primary failure to venetoclax in BCL2-rearranged lymphomas 2025 ·iScience ·Rajeswaran Mani,(unknown),M. Templeton,Lawrence J. Druhan,(unknown),Supriya Chakraborty,(unknown),(unknown),Hsih‐Te Yang,David Foureau,Nury Steuerwald,(unknown),Nilanjan Ghosh,Edward A. Copelan,Donald L. Durden,Belinda R. Avalos,Steven Park	0
2	CSF3R Splicing Regulates Granulopoiesis Via Splice Variant Specific Responses to G-CSF 2021 ·Blood ·(unknown),Rajeswaran Mani,(unknown),Belinda R. Avalos,Lawrence J. Druhan	1
3	Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia 2020 ·Cytotherapy ·Rajeswaran Mani,(unknown),(unknown),(unknown),(unknown),Xiaokui Mo,John C. Byrd,Dean A. Lee,Natarajan Muthusamy,Sumithira Vasu	14
4	ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model 2019 ·Blood ·Chi‐Ling Chiang,(unknown),Frank Frissora,Zhiliang Xie,Pearlly S. Yan,Ralf Bundschuh,Logan A. Walker,Xiaomeng Huang,Rajeswaran Mani,Xiaokui Mo,Sivasubramanian Baskar,Christoph Rader,Mitch A. Phelps,Guido Marcucci,John C. Byrd,L. James Lee,Natarajan Muthusamy	33
5	Abstract 1541: Evaluation of ROR1 targeted antibody drug conjugate in ROR1 positive leukemia 2019 ·Cancer Research ·Eileen Hu,Priscilla Do,Rajeswaran Mani,Frank Frissora,Rebecca M. Pearson,Gerard Lozanski,Haiyong Peng,Lorenz Waldmeier,Roger R. Beerli,Christoph Rader,Ulf Grawunder,John C. Byrd,Natarajan Muthusamy	1
6	The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34⁺CD123⁺ cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donors 2018 ·Haematologica ·Rajeswaran Mani,(unknown),Bhavani Gopalakrishnan,(unknown),(unknown),(unknown),Xiaokui Mo,Amber Gordon,Donna Bucci,David Lucas,Alice S. Mims,Christopher Brooks,Adrienne M. Dorrance,Alison Walker,William Blum,John C. Byrd,Gerard Lozanski,Sumithira Vasu,Natarajan Muthusamy	33
7	Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia 2018 ·Blood ·Mary K. McKenna,Sunil K. Noothi,Sara S. Alhakeem,Karine Z. Oben,J.T. Greene,Rajeswaran Mani,(unknown),(unknown),(unknown),(unknown),Roger A. Fleischman,Eric B. Durbin,John C. Byrd,Chi Wang,Natarajan Muthusamy,Vivek M. Rangnekar,Subbarao Bondada	6
8	MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia 2017 ·Science Signaling ·Kostandin V. Pajcini,Lanwei Xu,(unknown),Jelena Petrovic,Karol Palasiewicz,(unknown),Will Bailis,(unknown),Gerald Wertheim,Rajeswaran Mani,Natarajan Muthusamy,Yunlei Li,Jules P.P. Meijerink,Stephen C. Blacklow,Robert B. Faryabi,Sara Cherry,Warren S. Pear	15
9	OSU-2S, a Novel PKC Activator, Mediates PKC Dependent Cell Death, Differentiation and Cell Cycle Arrest in Acute Myeloid Leukemia 2017 ·Blood ·(unknown),Rajeswaran Mani,Xiaokui Mo,Pearlly S. Yan,Michael Broe,Ralf Bundschuh,(unknown),(unknown),Zhiliang Xie,Donna Bucci,David Lucas,Allison R. Walker,Alice S. Mims,Rebecca B. Klisovic,Ching‐Shih Chen,John C. Byrd,Mitch A. Phelps,Sumithira Vasu,Natarajan Muthusamy	1
10	Evaluation of ROR1 Targeted Antibody Drug Conjugates in Acute and Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma 2017 ·Blood ·Eileen Hu,Priscilla Do,Rajeswaran Mani,Frank Frissora,Haiyong Peng,Lorenz Waldmeier,Roger R. Beerli,Christoph Rader,Ulf Grawunder,John C. Byrd,Natarajan Muthusamy	1
11	Tumor Antigen ROR1 Targeted Delivery of MiR-29b in Chronic Lymphocytic Leukemia Induces Epigenetic Reprograming Resulting in Cell Cycle Arrest 2017 ·Blood ·Chi‐Ling Chiang,(unknown),Rajeswaran Mani,Frank Frissora,Zhiliang Xie,Xiaomeng Huang,Sivasubramanian Baskar,Christoph Rader,Mitch A. Phelps,Guido Marcucci,John C. Byrd,James L. Lee,Natarajan Muthusamy	2
12	Oxidative stress-induced JNK/AP-1 signaling is a major pathway involved in selective apoptosis of myelodysplastic syndrome cells by Withaferin-A 2017 ·Oncotarget ·Karine Z. Oben,Sara S. Alhakeem,Mary K. McKenna,J. Anthony Brandon,Rajeswaran Mani,Sunil K. Noothi,Jinpeng Liu,Shailaja Akunuru,Sanjit K. Dhar,Inder Pal Singh,Ying Liang,Chi Wang,Ahmed Abdel‐Latif,Harold F. Stills,Daret K. St. Clair,Hartmut Geiger,Natarajan Muthusamy,Kaoru Tohyama,Ramesh C. Gupta,Subbarao Bondada	18
13	Non‐immunosuppressive FTY720‐derivative OSU‐2S mediates reactive oxygen species‐mediated cytotoxicity in canine B‐cell lymphoma 2016 ·Veterinary and Comparative Oncology ·Rajeswaran Mani,(unknown),Xiaokui Mo,Ching-Shih Chen,Mitch A. Phelps,Rebecca B. Klisovic,John C. Byrd,William C. Kisseberth,Cheryl A. London,Natarajan Muthusamy	7
14	CD33 Targeted Immunoliposomal Delivery of OSU-2S, a Non-Immunosuppressive FTY720 Derivative, Mediates Selective Cytotoxicity in Acute Myeloid Leukemia 2016 ·Blood ·(unknown),Rajeswaran Mani,Chi‐Ling Chiang,Frank Frissora,Xiaokui Mo,Zhiliang Xie,Donna Bucci,Amber Gordon,David Lucas,William Blum,Alison R. Walker,Alice S. Mims,Rebecca B. Klisovic,Ching‐Shih Chen,Robert J. Lee,John C. Byrd,Mitch A. Phelps,Sumithira Vasu,Natarajan Muthusamy	1
15	SL-401 Mediates Potent Cytotoxicity Against CD123+ AML and MDS with Excess Blasts and Demonstrates Therapeutic Benefit in PDX Model 2016 ·Blood ·Rajeswaran Mani,(unknown),Bhavani Gopalakrishnan,(unknown),(unknown),(unknown),Xiaokui Mo,Amber Gordon,Donna Bucci,David Lucas,Christopher Brooks,Alison R. Walker,William Blum,John C. Byrd,Gerard Lozanski,Sumithra Vasu,Natarajan Muthusamy	1
16	ROR1-targeted delivery of OSU-2S, a nonimmunosuppressive FTY720 derivative, exerts potent cytotoxicity in mantle-cell lymphoma in vitro and in vivo 2015 ·Experimental Hematology ·Rajeswaran Mani,Chi‐Ling Chiang,Frank Frissora,(unknown),Xiaokui Mo,Sivasubramanian Baskar,Christoph Rader,Rebecca B. Klisovic,Mitch A. Phelps,Ching-Shih Chen,Robert J. Lee,John C. Byrd,Robert A. Baiocchi,L. James Lee,Natarajan Muthusamy	18
17	Tumor Antigen ROR1 Targeted Delivery Of FTY720 Derivative OSU-2S Prolongs Survival In ROR1 Engineered Mouse Model Of Chronic Lymphocytic Leukemia 2013 ·Blood ·Rajeswaran Mani,Yicheng Mao,Frank Frissora,Chi‐Ling Chiang,Jiang Wang,Yuan Zhao,Yun Wu,Bo Yu,(unknown),Xiaokui Mo,Sivasubramanian Baskar,Christoph Rader,Mitch A. Phelps,Robert J. Lee,Ching‐Shih Chen,James Lee,John C. Byrd,Natarajan Muthusamy	1
18	Dual Targeting of the Cyclin/Rb/E2F and Mitochondrial Pathways in Mantle Cell Lymphoma with the Translation Inhibitor Silvestrol 2012 ·Clinical Cancer Research ·Lapo Alinari,Courtney Prince,Ryan B. Edwards,William H. Towns,Rajeswaran Mani,Amy Lehman,Xiaoli Zhang,David Jarjoura,Li Pan,A. Douglas Kinghorn,Michael R. Grever,Robert A. Baiocchi,David Lucas	33
19	OSU‐DY7, a novel D‐tyrosinol derivative, mediates cytotoxicity in chronic lymphocytic leukaemia and Burkitt lymphoma through p38 mitogen‐activated protein kinase pathway 2011 ·British Journal of Haematology ·Li‐Yuan Bai,Yihui Ma,Samuel K. Kulp,Shu‐Huei Wang,Chang‐Fang Chiu,Frank Frissora,Rajeswaran Mani,Xiaokui Mo,David Jarjoura,John C. Byrd,Ching‐Shih Chen,Natarajan Muthusamy	6
20	FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death 2011 ·Blood ·Lapo Alinari,Emilia Mahoney,John T. Patton,Xiaoli Zhang,Lenguyen Huynh,(unknown),Rajeswaran Mani,Yicheng Mao,Bo Yu,Carl Quinion,William H. Towns,Ching‐Shih Chen,David M. Goldenberg,Kristie A. Blum,John C. Byrd,Natarajan Muthusamy,Mette Prætorius-Ibba,Robert A. Baiocchi	42

About Rajeswaran Mani

Rajeswaran Mani is a scholar working on Genetics, Immunology and Hematology, having authored 25 papers that have together received 293 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (11 papers), Sphingolipid Metabolism and Signaling (4 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Hematology (51 citations), Genetics (41 citations) and Immunology (70 citations). Rajeswaran Mani has collaborated with scholars based in United States, Poland and Austria. Frequent co-authors include Natarajan Muthusamy, John C. Byrd, Robert A. Baiocchi, Lapo Alinari, Xiaokui Mo, Xiaoli Zhang, Ching-Shih Chen, William H. Towns, David Lucas and Fengting Yan. Their work appears in journals such as Blood, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact